PADI4 and breast cancer: Studies have shown that the citrullination of H3R17 by PAD4 on the ER-regulated pS2 promoter caused a significant decrease in estrogen-induced gene expression in MCF-7 breast cancer cells by interfering with methylation events mediated by CARM1 (also known as PRMT4) [14].